1973
DOI: 10.1056/nejm197307052890107
|View full text |Cite
|
Sign up to set email alerts
|

The Cellular Basis of Metabolic Bone Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

9
116
1
7

Year Published

1977
1977
2009
2009

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 170 publications
(133 citation statements)
references
References 1 publication
9
116
1
7
Order By: Relevance
“…The reduction of the PTH secretion and the increased or normal CT level should modify the properties of the bone cells. According to Rasmussen and Bordier (1973), the sideration of the parathyroid function, although the C cells function remain normal, might diminish the resorption activity of the osteoclasts and accelerate the differ entiation of osteoclasts into osteoblasts. The osteoblastic activation should permit the repair of the bone resorption.…”
Section: Discussionmentioning
confidence: 99%
“…The reduction of the PTH secretion and the increased or normal CT level should modify the properties of the bone cells. According to Rasmussen and Bordier (1973), the sideration of the parathyroid function, although the C cells function remain normal, might diminish the resorption activity of the osteoclasts and accelerate the differ entiation of osteoclasts into osteoblasts. The osteoblastic activation should permit the repair of the bone resorption.…”
Section: Discussionmentioning
confidence: 99%
“…In early views, the responses of osteoclasts and BMUs to parathyroid hormone, calcitonin, and other humoral agents were viewed as essential for calcium homeostasis (Albright and Reifenstein, 1948;Barzel, 1970;Favus, 1999;Rasmussen and Bordier, 1974;Snapper, 1957). Some people even viewed that as their chief function.…”
Section: Homeostasis and Bonementioning
confidence: 99%
“…The proclivity to sarcomatous transformation, the variability of osteoblasts (size, shape, and staining), the peculiarity of osteoclasts (size and number of nuclei, up to 100, seen also in giant-cell tumors), and control of the disease by antimitotic agents such as plicamycin (also known as mithramycin) suggest that the disease may be a benign neoplasm of the mesenchymal osteoprogenitor cell, as was hypothesized by Rasmussen and Bordier in 1973 [125].…”
Section: Etiologymentioning
confidence: 89%